Sepracor, Breath Settle Xopenex Patent Fight
Sepracor Inc. has settled a patent lawsuit against rival Breath Ltd. over Sepracor's inhaled asthma drug Xopenex, allowing Breath to sell a generic version of the drug in exchange for a...To view the full article, register now.
Already a subscriber? Click here to view full article